JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) Sees Large Decline in Short Interest

JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) was the target of a significant decrease in short interest in January. As of January 31st, there was short interest totalling 338,200 shares, a decrease of 19.7% from the January 15th total of 421,200 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.

JCR Pharmaceuticals Stock Performance

OTCMKTS JCRRF remained flat at $4.57 during trading hours on Monday. The company’s fifty day moving average price is $4.57 and its 200 day moving average price is $4.54. JCR Pharmaceuticals has a 12-month low of $4.30 and a 12-month high of $4.70.

JCR Pharmaceuticals Company Profile

JCR Pharmaceuticals Co, Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V.